Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Short term treatment with Trimetazidine on indirect cardiac performance measurements and pulse wave velocity rates in patients with ischemic left ventricular dysfunction and Diabetes Mellitus

Next Previous
Trial Profile

Effect of Short term treatment with Trimetazidine on indirect cardiac performance measurements and pulse wave velocity rates in patients with ischemic left ventricular dysfunction and Diabetes Mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Trimetazidine (Primary)
  • Indications Ischaemic heart disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 11 Jan 2018 New trial record
    • 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top